MetLife Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6M | Buy |
|
|||||
|
2025
Q1 | $7.51M | Sell |
|
|||||
|
2024
Q4 | $7.06M | Buy |
|
|||||
|
2024
Q3 | $6.91M | Sell |
|
|||||
|
2024
Q2 | $8.23M | Buy |
|
|||||
|
2024
Q1 | $399K | Buy |
|
|||||
|
2023
Q4 | $439K | Sell |
|
|||||
|
2023
Q3 | $410K | Buy |
|
|||||
|
2023
Q2 | $401K | Buy |
|
|||||
|
2023
Q1 | $372K | Buy |
|
|||||
|
2022
Q4 | $395K | Buy |
|
|||||
|
2022
Q3 | $322K | Sell |
|
|||||
|
2022
Q2 | $322K | Buy |
|
|||||
|
2022
Q1 | $281K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $21.5K | Buy |
|
|||||
|
2018
Q4 | $20.5K | Sell |
|
|||||
|
2018
Q3 | $23.6K | Buy |
|